Clinical Characteristics of Autoimmune Gastroparesis and Response to Immunomodulation.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of clinical gastroenterology"
DOI: 10.1097/mcg.0000000000002254
Abstract: INTRODUCTION Autoimmune factors may be involved in the development of gastroparesis, a subtype known as autoimmune gastrointestinal dysmotility (AGID). Small open label studies in AGID have demonstrated intravenous immunoglobulin (IVIG) therapy may lead to improvement… read more here.
Keywords: improvement; ivig therapy; gcsi; ivig ... See more keywords
Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/20406223221097331
Abstract: Introduction: Intravenous immunoglobulin (IVIG) was reported to be the third most used monotherapy in livedoid vasculopathy (LV). There is currently a lack of randomized controlled clinical trials and no standardized therapeutic regimen for IVIG therapy… read more here.
Keywords: systematic review; efficacy safety; intravenous immunoglobulin; ivig therapy ... See more keywords
Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults.
Sign Up to like & getrecommendations! Published in 2019 at "International heart journal"
DOI: 10.1536/ihj.18-299
Abstract: The efficacy of intravenous immunoglobulin (IVIG) in the treatment of acute myocarditis remains controversial. The aim of this study was to conduct a meta-analysis to assess the efficacy of IVIG in children and adults with… read more here.
Keywords: intravenous immunoglobulin; children adults; myocarditis; acute myocarditis ... See more keywords
Maintenance Intravenous Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: 18-Month Post-marketing Surveillance in 103 Patients
Sign Up to like & getrecommendations! Published in 2024 at "Internal Medicine"
DOI: 10.2169/internalmedicine.3661-24
Abstract: Objective The efficacy of maintenance intravenous immunoglobulin (IVIg) therapy has been established to prevent relapse in chronic inflammatory demyelinating polyneuropathy (CIDP). This prospective post-marketing surveillance study evaluated the treatment duration, efficacy, and safety of maintenance… read more here.
Keywords: relapse; maintenance; therapy; ivig therapy ... See more keywords
The EIF2AK4/rs4594236 AG/GG Genotype Is a Hazard Factor of Immunoglobulin Therapy Resistance in Southern Chinese Kawasaki Disease Patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.868159
Abstract: Background: Kawasaki disease (KD) is an acute, self-limited vasculitis disorder of unknown etiology in children. Immunologic abnormalities were detected during the acute phase of KD, which reflected that the effect cells of the activated immune… read more here.
Keywords: kawasaki disease; therapy; rs4594236 genotype; resistance ... See more keywords
Severe Gastrointestinal Complications After IVIG Infusion in Newborns: A Two-Center Study and Literature Review
Sign Up to like & getrecommendations! Published in 2024 at "Iranian Journal of Pediatrics"
DOI: 10.5812/ijp-144488
Abstract: Background: There are several studies regarding perforations after intravenous immunoglobulin (IVIG) infusion; however, the risk factors are not defined yet. Objectives: The present study aimed to investigate gastrointestinal complications in newborns regarding the reported immunoglobulin… read more here.
Keywords: ivig infusion; ivig therapy; gastrointestinal complications; study ... See more keywords